Preparation and characterization of porous crosslinked collagenous matrices containing bioavailable chondroitin sulphate

Biomaterials

Volumn 20, Issue 9, 1999, Pages 847-858

  Pieper, J S ^a   Oosterhof, A ^a   Dijkstra, P J ^b   Veerkamp, J H ^a   Van Kuppevelt, T H ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF TWENTE   (Netherlands)

Author keywords

Carbodiimide; Collagen matrix; Crosslinking; Dehydrothermal treatment; Glycosaminoglycans; Tissue engineering

Indexed keywords

BIODEGRADATION; COLLAGEN; CROSSLINKING; ENZYMES; ETHANOL; POROSITY; POROUS MATERIALS; SULFUR COMPOUNDS; TENSILE STRENGTH; TISSUE CULTURE;

BIOAVAILABILITY; CHONDROITIN SULFATE; DEHYDROTHERMAL TREATMENT; GLYCOSAMINOGLYCAN;

BIOMATERIALS;

ALCOHOL; AMINE; CHONDROITIN SULFATE; COLLAGEN; CYANAMIDE; GLYCOSAMINOGLYCAN;

ANIMAL TISSUE; ARTICLE; BIOAVAILABILITY; BIOMEDICAL ENGINEERING; COVALENT BOND; CROSS LINKING; DENATURATION; DIGESTION; FIBROBLAST; MYOBLAST; NONHUMAN; POROSITY; PRIORITY JOURNAL; SURFACE PROPERTY;

BIOCOMPATIBLE MATERIALS; BIOLOGICAL AVAILABILITY; CALORIMETRY, DIFFERENTIAL SCANNING; CELL SURVIVAL; CELLS, CULTURED; CHONDROITIN ABC LYASE; CHONDROITIN SULFATES; COLLAGEN; CROSS-LINKING REAGENTS; ENDOPEPTIDASES; ETHYLDIMETHYLAMINOPROPYL CARBODIIMIDE; FIBROBLASTS; HUMANS; MICROSCOPY, ELECTRON, SCANNING; MUSCLE, SKELETAL; PROTEIN BINDING; SKIN; STRESS, MECHANICAL; THERMODYNAMICS;

ANIMALIA;

EID: 0033135497     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(98)00240-3     Document Type: Article

References (50)

1. Chvapil M, Kronenthal L, van Winkle W. Medical and surgical applications of collagen. Int Rev Connect Tissue Res 1973;6:1-61.
2. Pachence JM. Collagen-based devices for soft tissue repair. J Biomed Mater Res 1996;33:35-40.
3. Yannas IV. Materials for skin and nerve regeneration; Biologically active analogs of the extracellular matrix. Mater Sci Technol 1992;14:179-208.
4. Doillon CJ, Silver FH, Berg RA. Fibroblast growth on a porous collagen sponge containing hyaluronic acid and fibronectin. Biomaterials 1987;8:195-200.
5. Shafritz TA, Rosenberg LC, Yannas IV. Specific effects of glycosaminoglycans in an analog of extracellular matrix that delays wound contraction and induces regeneration. Wound Repair and Regeneration 1994;2:270-6.
6. Srivastava S, Gorham SD, French DA, Shivas AA, Courtney JM. In vivo evaluation and comparison of collagen, acetylated collagen and collagen/glycosaminoglycan composite films and sponges as candidate biomaterials. Biomaterials 1990;11:155-61.
7. Boyce ST, Christianson DJ, Hansbrough JF. Structure of a collagen-GAG dermal skin substitute optimized for cultured human epidermal keratinocytes. J Biomed Mater Res 1988;22:939-57.
8. Jackson RI, Busch SJ, Cardin AD. Glycosaminoglycans: Molecular properties, protein interactions, and role in physiological processes. Physiol Rev 1991;71:481-539.
9. Stringer SE, Gallagher JT. Heparan sulphate. Int J Biochem Cell Biol 1997;29:709-14.
10. David G. Integral membrane heparan sulphate proteoglycans. FASEB J 1993;7:1023-30.
11. Toole BP. Proteoglycans and hyaluron in morphogenesis and differentiation. In: Hay EP, editor. Cell Biology of the Extracellular Matrix. New York, 1991:305-41.
12. Charriere G, Bejot M, Schnitzler L, Ville G, Hartmann J. Reactions to a bovine collagen implant. J Am Acad Dermatol 1990;21:1203-8.
13. Doillon CJ, Whyne CF, Brandwein S, Silver FH. Collagen-based wound dressings: Control of the pore structure and morphology. J Biomed Mater Res 1986;20:1219-28.
14. Yannas IV, Burke JF, Gordon PL, Huang C, Rubenstein RH. Design of an artificial skin. II. Control of chemical composition. J Biomed Mater Res 1980;14:107-31.
15. Langer R, Vacanti JP. Tissue engineering. Science 1993;260:920-6.
16. Raghunath K, Biswas G, Panduranga Rao K, Joseph KT, Chvapil M. Some characteristics of collagen-heparin complex. J Biomed Mater Res 1983;17:613-21.
17. Hanthamrongwit M, Reid WH, Grant MH. Chondroitin-6-sulphate incorporated into collagen gels for the growth of human keratinocytes: The effect of crosslinking agents and diamines. Biomaterials 1996;17:775-80.
18. Senatore F, Shankar H, Chen JH et al. In vitro and in vivo studies of heparinized- collageno-elastic tubes. J Biomed Mater Res 1990;24:939-57.
19. Nimni ME, Cheung DT, Strates B, Kodama M, Sheikh K. Bioprosthesis derived from cross-linked and chemically modified collagenous tissues. In: Nimni ME, editor. Collagen, vol. III. 1988:1-38.
20. Hardin-Young J, Carr RM, Downing GJ, Condon KD, Termin PL. Modification of native collagen reduces antigenicity but preserves cell compatibility. Biotechnol Bioeng 1996;49:675-82.
21. van Luyn MJA, van Wachem PB, Olde Damink LHH, Dijkstra PJ, Feijen J, Nieuwenhuis P. Relations between in vitro cytotoxicity and crosslinked dermal sheep collagens. J Biomed Mater Res 1992;26:1091-10.
22. Kemp PD, Cavallaro JF, Hastings DN. Effects of carbodiimide crosslinking and load environment on the remodeling of collagen scaffolds. Tissue Engng 1995;1:71-9.
23. van Wachem PB, van Luyn MJA, Olde Damink LH, Dijkstra PJ, Feijen J, Nieuwenhuis P. Biocompatibility and tissue regenerating capacity of crosslinked dermal sheep collagen. J Biomed Mater Res 1994;28:353-63.
24. Light ND. Collagen in skin: Preparation and analysis. In: Skerrow D, editor. Methods in Skin Research. 1985:559-86.
25. Miller EJ, Rhodes RK. Preparation and characterization of the different types of collagen. Methods Enzymol 1982;82:33-64.
26. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
27. Einarsson S, Josefson B, Lagerkwist S. Determination of amino acids with 9-fluorenylmethyl-chloroformate and reversed-phase high-performance liquid chromatography. J Chromatogr 1983;282:609-18.
28. Olde Damink LHH, Dijkstra PJ, van Luyn MJA, van Wachem PB, Nieuwenhuis P, Feijen J. Crosslinking of dermal sheep collagen using a water-soluble carbodiimide. Biomaterials 1996;17:765-73.
29. Bernal VM, Stanley DW. Changes in the melting characteristics of bovine tendon induced by a bacterial collagenase. J Food Sci 1986;51:834-7.
30. Cheung DT, Perelman N, Ko EC, Nimni ME. Mechanism of crosslinking of proteins by glutaraldehyde III. Reaction with collagen in tissues. Connect Tissue Res 1985;13:109-15.
31. Benders AAGM, van Kuppevelt TH, Oosterhof A, Veerkamp JH. The biochemical andstructural maturation of human skeletal muscle cells in culture: The effect of the serum substitute Ultroser G. Exp Cell Res 1991;195:284-94.
32. Geesin JC, Brown LJ, Liu Z, Berg RA. Development of a skin model based on insoluble fibrillar collagen. J Biomed Mater Res 1996;33:1-8.
33. Anselme K, Bacques C, Charriere G et al. Tissue reaction to subcutaneous implantation of a collagen sponge. A histological, ultrastructural and immunological study. J Biomed Mater Res 1990;24:689-703.
34. Weadock K, Olson RM, Silver FH. Evaluation of collagen crosslinking techniques. Biomater Med Devices Artif Organs 1984;11:293-318.
35. Khor E. Methods for the treatment of collagenous tissues for bioprostheses. Biomatenals 1997;18:95-105.
36. Meade KR, Silver FH. Immunogenicity of collagenous implants. Biomaterials 1990;11:176-80.
37. Wang MC, Pins GD, Silver FH. Collagen fibres with improved strength for the repair of soft tissue injuries. Biomaterials 1994;15:507-12.
38. Gorham SD, Light ND, Diamond AM et al. Effect of chemical modifications on the susceptibility of collagen to proteolysis. II. Dehydrothermal crosslinking. Int J Biol Macromol 1992;14:129-38.
39. Weadock KS, Miller EJ, Keuffel EL, Dunn MG. Effect of physical crosslinking methods on collagen-fiber durability in proteolytic solutions. J Biomed Mater Res 1996;32:221-6.
40. Grabarek Z, Gergely J. Zero-length crosslinking procedure with the use of active esters. Anal Biochem 1990;185:131-5.
41. Fields GB. The collagen triple-helix: Correlation of conformation with biological activities. Connect Tissue Res 1995;31:235-43.
42. Tomihata K, Ikada Y. Crosslinking of hyaluronic acid with water-soluble carbodiimide. J Biomed Mater Res 1997;37:243-51.
43. Gratzer PF, Pereira CA, Lee JM. Solvent environment modulates effects of glutaraldehyde crosslinking on tissue-derived biomaterials. J Biomed Mater Res 1996;31:533-43.
44. Vyavahare NR, Hirsch D, Lerner E et al. Prevention of calcification of glutaraldehyde-crosslinked porcine aortic cusps by ethanol preincubation: Mechanistic studies of protein structure and water-biomaterial relationships. J Biomed Mater Res 1998;40:577-85.
45. Matsuda K, Suzuki S, Isshiki N, Ikada Y. Re-freeze dried bilayer artificial skin. Biomaterials 1993;14:1030-5.
46. Kurzer F, Douraghi-Zadeh K. Advances in the chemistry of carbodiimides. Chemical Rev 1967;67:107-50.
47. Khorana HG. The chemistry of carbodiimides. Chem Rev 1953;53:145-66.
48. Nakajima N, Ikada Y. Mechanism of amide formation by carbodiimide for bioconjugation in aqueous media. Bioconjug Chem 1995;6:123-30.
49. Okano T, Matsuda T. Hybrid muscular tissues: Preparation of skeletal muscle cell-incorporated collagen gels. Cell Transplant 1997;6:109-18.
50. Grande DA, Halberstadt C, Naughton G, Schwartz R, Manji R. Evaluation of matrix scaffolds for tissue engineering of articular cartilage grafts. J Biomed Mater Res 1997;34:211-20.